Clinical grade monoclonal antibody UB-421 includes: one 100-liter batch of GMP-manufacturer UB-421, sterile vialing, and long-term and accelerated stability studies.
Ended Purchase Order Awarded Last action
- Contract number
- 75N93024P01131
- Awardee
-
United Biopharma, Inc. UEI KWMNCKBPM4K6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,000
Award facts
- Opportunity
-
- Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody Pre-Solicitation · NOINIAID242226773 · Posted Jul 11, 2024
- Contract value 100% obligated
- $400,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $400,000 |
About this award
This federal contract award to United Biopharma, Inc., a for-profit organization located in Taiwan, is for the delivery of a Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody designated UB-421. The contract, valued at $400,000.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. The scope includes the production of a 100-liter batch of the GMP-manufactured UB-421 monoclonal antibody, sterile vialing, and stability studies. The original solicitation specified requirements such as high-affinity binding, potent biological activity, and strict purity and safety standards for the antibody product.
Quick answers
Who was awarded contract 75N93024P01131?
75N93024P01131 was awarded to United Biopharma, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024P01131 worth?
The government has obligated $400,000 on 75N93024P01131.
Was contract 75N93024P01131 competed?
The extent of competition for 75N93024P01131 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award